Xiaohong He
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical Trial.
Journal: JAMA network open
Published: May 08, 2026
Structural Characterization and Emulsifying Properties of Highly Soluble Macadamia-Soybean Protein Composites Fabricated by Alkaline-Thermal Treatment.
Journal: Foods (Basel, Switzerland)
Published: November 17, 2025
Rheumatoid arthritis and gout: a rare combination or overlooked coexistence?
Journal: Arthritis research & therapy
Published: June 07, 2025
Multiomics Identifies Potential Biomarkers in Ankylosing Spondylitis Bone Formation.
Journal: Human mutation
Published: May 12, 2025
Exploring the Potential of an Industry-Scale Microfluidizer for Modifying Rice Starch: Multi-Layer Structures and Physicochemical Properties.
Journal: Foods (Basel, Switzerland)
Published: May 09, 2025
Trigonelline Shields Chondrocytes from Oxidative Damage in Osteoarthritis through Activation of the Keap1/Nrf2/ARE Signaling Pathway.
Journal: Applied biochemistry and biotechnology
Published: April 21, 2025
Traditional Chinese medicine constitution types and apolipoprotein B in hyperuricemia: Associations with cardiovascular risk.
Journal: Journal of medical biochemistry
Published: March 12, 2025
Elucidation of the anti-arthritic mechanism of Guizhi-Shaoyao-Zhimu decoction by reshaping circadian rhythm.
Journal: Pharmacological research
Published: January 27, 2025
Molecular insights into the therapeutic mechanisms of Bushen-Qiangdu-Zhilv decoction for ankylosing spondylitis.
Journal: Journal of ethnopharmacology
Published: October 17, 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial.
Journal: Annals of the rheumatic diseases
Published: July 08, 2024
Triptolide inhibits the proinflammatory potential of myeloid-derived suppressor cells via reducing Arginase-1 in rheumatoid arthritis.
Journal: International immunopharmacology
Published: October 16, 2023
Last Updated: 09/26/2026